GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » ROA %
中文

Psyence Biomedical (Psyence Biomedical) ROA %

: -183.31% (As of Mar. 2023)
View and export this data going back to 2024. Start your Free Trial

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Psyence Biomedical's annualized Net Income for the quarter that ended in Mar. 2023 was $-3.10 Mil. Psyence Biomedical's average Total Assets over the quarter that ended in Mar. 2023 was $1.69 Mil. Therefore, Psyence Biomedical's annualized ROA % for the quarter that ended in Mar. 2023 was -183.31%.

The historical rank and industry rank for Psyence Biomedical's ROA % or its related term are showing as below:

PBM' s ROA % Range Over the Past 10 Years
Min: -183.31   Med: -118.9   Max: -54.48
Current: -183.31

During the past 3 years, Psyence Biomedical's highest ROA % was -54.48%. The lowest was -183.31%. And the median was -118.90%.

PBM's ROA % is ranked worse than
92.28% of 1555 companies
in the Biotechnology industry
Industry Median: -35.41 vs PBM: -183.31

Psyence Biomedical ROA % Historical Data

The historical data trend for Psyence Biomedical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
ROA %
- -54.48 -183.31

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
ROA % - -54.48 -183.31

Competitive Comparison

For the Biotechnology subindustry, Psyence Biomedical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical ROA % Distribution

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's ROA % distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's ROA % falls into.



Psyence Biomedical ROA % Calculation

Psyence Biomedical's annualized ROA % for the fiscal year that ended in Mar. 2023 is calculated as:

ROA %=Net Income (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=-3.097/( (1.806+1.573)/ 2 )
=-3.097/1.6895
=-183.31 %

Psyence Biomedical's annualized ROA % for the quarter that ended in Mar. 2023 is calculated as:

ROA %=Net Income (Q: Mar. 2023 )/( (Total Assets (Q: Mar. 2022 )+Total Assets (Q: Mar. 2023 ))/ count )
=-3.097/( (1.806+1.573)/ 2 )
=-3.097/1.6895
=-183.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (Mar. 2023) net income data. ROA % is displayed in the 30-year financial page.


Psyence Biomedical  (NAS:PBM) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2023 )
=Net Income/Total Assets
=-3.097/1.6895
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.097 / 0)*(0 / 1.6895)
=Net Margin %*Asset Turnover
=N/A %*0
=-183.31 %

Note: The Net Income data used here is one times the annual (Mar. 2023) net income data. The Revenue data used here is one times the annual (Mar. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Psyence Biomedical ROA % Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines